期刊文献+

定期体外反搏对冠心病患者内皮脂酶的影响

The effect of regular external counterpulsation on plasma endothelial lipase concentration in patients with coronary heart disease
下载PDF
导出
摘要 目的探讨定期体外反搏对冠心病患者血浆内皮脂酶水平的影响和意义。方法选择冠心病患者65例,分为定期反搏组(30例)和药物治疗组(35例)。采用酶联免疫吸附双抗体夹心法定量测定两组血浆内皮脂酶水平,同时测定血脂(HDL-C、TG、LDL-C、TC)和C反应蛋白的水平。结果定期反搏组血浆内皮脂酶水平和C反应蛋白水平分别为(339.74±40.32)μg/L和(2.17±0.34)mg/L,药物治疗组分别为(745.12±51.15)μg/L和(2.50±0.44)mg/L,两组之间血浆内皮脂酶和C反应蛋白水平的差异均有统计学意义(均为P<0.05)。两组中的血浆内皮脂酶与C反应蛋白水平呈正相关关系(r=0.37,P<0.05),而血浆内皮脂酶与血脂无相关性。结论定期体外反搏治疗能显著降低冠心病患者血浆内皮脂酶水平,提示体外反搏改善血管内皮功能可能与这种机制有关。 Objective To investigate the effect of regular external counterpulsation (ECP) on plasma endothelial lipase(EL) in patients with coronary heart disease (CHD). Methods Sixty-five patients with CHD were recruited. They were divided into regular ECP group ( n = 30) and drug treatment group ( n = 35 ). Plasma EL level was measured by enzyme linked immunosorbent assay (ELISA) in each group and high density lipoprotein, triglyceride, tow lipoprotein, fasting glucose and C reactive protein (CRP) were measured in both groups. Results The levels of plasma EL and CRP in the regular ECP group were (339. 74±40. 32)μg/L and (2. 17±0. 34) mg/L, respectively. The levels of plasma EL and CRP in the drug treatment group were (745.12±51.15) μg/L and (2.50 ±0.44) mg/L, respectively. The difference in the level of plasma EL and CRP between the 2 groups was significant ( all P 〈 0. 05 ). There was a significantly positive correlation between plasma EL and CRP in each group ( r = 0. 37, P 〈 0. 05 ). However, Plasma EL level was not related to the level of lipids. Conclusions Regular ECP treatment can significantly lower the level of plasma EL in patients with CHD. The beneficial effect of ECP on endothelial function may be related to the above mechanism.
出处 《中国心血管杂志》 2009年第5期346-348,共3页 Chinese Journal of Cardiovascular Medicine
基金 国家自然科学基金青年基金项目(30800215)
关键词 反搏动术 脂肪酶 冠状动脉疾病 Counterpulsation Lipase Coronary artery disease
  • 相关文献

参考文献11

  • 1Ishida T, Choi S, Kundu RK, et al. Endothelial lipase is a major determinant of HDL level. J Clin Invest,2003,11:347-355.
  • 2Maugeais C, Tietge UJ, Broedl UC, et al. Dose-dependent acceleration of high-density lipoprotein catabolism by endothelial lipase. Circulation, 2003, 108 : 2121-2126.
  • 3Hasham SN, Pillarisetti S. Vascular lipases, inflammation and atherosclerosis. Clin Chim Acta, 2006, 372: 179-183.
  • 4Kojma Y, Hirata K, Ishida T, et al. Endothelial lipase modulates monocyte adhesion to the vessel wall: A potential role in inflammation. J Biol Chem,2004, 279: 54032-54038.
  • 5Hirata K, Dichek HL, Cioffi JA, et al. Cloning of a unique lipase from endothelial cells extends the lipase gene family. J Biol Chem, 1999, 274 : 14170-14175.
  • 6蒋涛,顾熊飞,马涧泉,周少春,郑振声,詹澄扬.体外反搏治疗失血性休克中一氧化氮合酶的变化[J].中国病理生理杂志,1998,14(3):243-245. 被引量:7
  • 7Hirata K,lshida T, Matsushita H, et al. Regulated expression of endothelial cell-derived lipase. Biochem Biophys Res Commun, 2000, 272:90-93.
  • 8Badellino KO,Wolfe ML, Reilly MP,et al. Endothelial lipase is increased in vivo by inflammation in humans. Circulation, 2008, 117:678-685.
  • 9Badellino KO, Wolfe ML, Reilly MP, et al. Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. Plos Med,2006, 3:e22.
  • 10许灿新,王春,朱炳阳,秦旭平,廖端芳.内皮脂酶在载脂蛋白E基因缺陷小鼠主动脉粥样斑块中的表达[J].美国中华临床医学杂志,2006,8(1):42-44. 被引量:1

二级参考文献3

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部